Healthcare Logic for Growth

In this episode of Healthcare Logic for Growth, we break down the pivotal trends from the first half of 2026 that every small and start-up healthcare company needs to know. We explore the good news (rebounding venture funding, FDA fast-track vouchers, and digital health pilot programs), the bad news (FDA staffing shortages, drug pricing uncertainty, and OMB grant threats), and the "data trap" catc...

In this episode of Healthcare Logic for Growth, we break down what healthcare startups need to do to succeed - and why so many fail. We cover the five biggest success factors, including solving a real problem, proving outcomes, building the payment model early, fitting into clinical workflows, and scaling with trust. We also look at five common failure patterns, including weak validation, no reimb...

The MFN drug pricing framework - what began as voluntary agreements with sixteen of the largest pharmaceutical companies - is now moving toward mandatory rules that will reach smaller biotechs and pharma companies. At the same time, a 100% pharmaceutical tariff takes effect September 29th for smaller manufacturers, with a lower 20% rate available only to companies that have engaged the MFN framewo...

Healthcare is full of great products that never became great businesses. In this first episode of the Healthcare Startup Revenue Series, we break down 4 of the structural barriers that accelerate performance: Buyer vs. user separation Long purchasing cycles The evidence requirement Economic model misalignment Whether you’re still in your first year of commercial activity or stuck at early customer...

On May 1, 2026, the CMS BALANCE Model went live - opening the door for Medicaid agencies to begin enrolling in a new federal framework that expands GLP-1 coverage for obesity and metabolic disease. The Medicare GLP-1 Bridge follows on July 1st, giving Medicare Part D beneficiaries access to these drugs at $50 per month. Most of the conversation has focused on Novo Nordisk and Eli Lilly. This episo...

Healthcare is deploying AI tools at more than twice the rate of the broader economy — and for the first time at meaningful scale, the ROI is real and documented. In this episode, we unpack the NVIDIA State of AI in Healthcare 2026 survey and this week's Healthcare IT News report on AI payment alignment to answer the question every small healthcare company is quietly asking: what does the AI inflec...

On May 1st, 2026, Nebraska became the first state in the country to enforce Medicaid work requirements under the One Big Beautiful Bill Act - the sweeping federal law that includes nearly a trillion dollars in Medicaid cuts over ten years. Montana goes live July 1st. Iowa in December. And 43 states are federally required to follow by January 1st, 2027. In this episode, we break down what this mean...

On April 23, 2026, the FDA and CMS announced the RAPID coverage pathway - a new program designed to cut the historically long gap between FDA device authorization and Medicare coverage from a year or more down to as little as two months. For early-stage life science device companies, this changes the commercial math. In this episode, we break down exactly what RAPID is, who qualifies, what it mean...

Biotech in 2026 is operating inside a Triple Threat. In this episode, we break down the three forces hitting simultaneously: capital pressure that now demands commercial readiness alongside clinical proof, clinical complexity that has turned trial design into a commercial decision, and commercial infrastructure gaps that show up at the worst possible moment - right when you need them most.   If yo...

In this opening episode of the Early-Stage Life Science series, host Eric delivers an honest 30,000-foot assessment of what early-stage life science companies are up against in 2026. Not the headline version. The operational reality. WHY THIS EPISODE MATTERS The life sciences landscape looks strong from the outside -  a recovering biotech index, active M&A, and AI transforming drug discov...

Actionable Insights and Go-Forward-Strategies for Hospitals, Clinics, Home Health, and Emerging Healthcare Companies Welcome to Healthcare Logic for Growth, the podcast from Life Science Logic where clinical breakthroughs meet commercial reality, where hospitals near-term challenges are discussed and translate into keeping the doors open, where healthcare leadership and their team can discover a r...